帕金森病中轻度认知障碍的预测模型使用视觉评分尺度
Chiara Fornari1, Claudia Meli1, Giuseppe Rabini1
1Center for Mind/Brain Sciences-CIMeC, University of Trento, Corso Bettini 31, Rovereto, 38068, TN, Italy.
概括
使用中叶缩 (MTA) 和叶 (OC) 尺度对脑缩的视觉评估可以帮助早期检测帕金森病 (PD) 患者的轻度认知障碍.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 认知科学 认知科学
背景情况:
- 在帕金森病 (PD) 中早期发现认知障碍对于预防痴呆至关重要.
- 脑缩评估可以作为一个生物标志物来区分患有轻度认知障碍 (PD-MCI) 的PD患者和没有 (PD-CU) 的PD患者.
研究的目的:
- 调查视觉评分尺度用于评估脑缩在检测MCI在PD患者的实用性.
- 用视力缩量表来区分患有或没有认知障碍的PD患者.
主要方法:
- 29名PD患者 (16名PD-CU,13名PD-MCI) 和12名健康对照 (HC) 接受了认知评估和MRI.
- 两个评分员使用视觉评分表 (MTA,OC) 评估大脑缩;评分员之间的一致性被评估.
- 使用ANCOVA,后期测试和后勤回归来分析群体差异并确定预测因素.
主要成果:
- 视觉评级尺度显示了良好的优秀的评级者之间的协议.
- 与PD-CU患者和HC患者相比,PD-MCI患者的MTA和OC缩得分显著更高.
- MTA评分预测了PD组内的认知概况,而OC评分则区分了PD-MCI与HC.
结论:
- 对MTA和OC缩的视觉评估可以帮助识别PD的认知障碍.
- OC缩在区分健康对照和认知受损的PD患者中特别有用.
相关概念视频
01:15Parkinson's Disease: Overview
723
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
723
01:24Parkinson's Disease: Treatment
391
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
391